COMP <GO>
BLCO vs LLY // FREE CASH FLOW YIELD
Bausch + Lomb Corporation (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: BLCO 3
— LLY 12
▲ FREE CASH FLOW YIELD LEADER: LLY
LAST: $20.00 (-1.96%) • MKT CAP: $7.29B
fcf-yield
-0.90%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
fcf-yield
2.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLCO VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLCO | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 83.64% | -42.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 32.36% | -31.56 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.1x | 36.4x | -7.32 | BLCO | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -0.90% | 2.30% | -3.20 | LLY | /fcf-yield <GO> |
| Operating Margin | 2.20% | 40.21% | -38.01 | LLY | /operating-margins <GO> |
| Net Profit Margin | -7.10% | 31.90% | -39.00 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 45.51% | -39.01 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.97 | 9.29 | -8.32 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.77% | +0.33 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.8 | 77.9 | -4.03 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.51 | +0.55 | BLCO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 26.3x | -3.25 | BLCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.29B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLCO REV | LLY REV | BLCO GROSS % | LLY GROSS % | BLCO FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.10B | $65.18B | 44.0% | 83.0% | -$66.0M | $16.81B |
| FY 2024 | $4.79B | $45.04B | 44.0% | 81.3% | -$59.0M | $8.82B |
| FY 2023 | $4.15B | $34.12B | 44.0% | 79.3% | -$203.6M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLCO // BETA 1.06
LLY // BETA 0.51